Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
22.07
+0.49 (2.27%)
At close: Mar 6, 2026, 4:00 PM EST
22.39
+0.32 (1.45%)
After-hours: Mar 6, 2026, 5:22 PM EST
Syndax Pharmaceuticals Employees
Syndax Pharmaceuticals had 298 employees as of December 31, 2025. The number of employees increased by 28 or 10.37% compared to the previous year.
Employees
298
Change (1Y)
28
Growth (1Y)
10.37%
Revenue / Employee
$578,362
Profits / Employee
-$957,792
Market Cap
1.95B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Recursion Pharmaceuticals | 800 |
| Zymeworks | 263 |
| Celldex Therapeutics | 198 |
| Soleno Therapeutics | 182 |
| Aurinia Pharmaceuticals | 128 |
| Stoke Therapeutics | 128 |
| Mesoblast | 81 |
SNDX News
- 3 days ago - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - Syndax Pharmaceuticals, Inc. (SNDX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 12 days ago - Syndax Announces Participation in March Investor Conferences - GlobeNewsWire
- 16 days ago - Syndax to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on February 26, 2026 - GlobeNewsWire
- 23 days ago - Syndax Pharmaceuticals' Early Launch Success Signals Continued Growth Into 2026 - Seeking Alpha
- 4 weeks ago - Syndax Announces Participation at the 2026 Guggenheim Emerging Outlook: Biotech Summit - GlobeNewsWire
- 7 weeks ago - Syndax Pharmaceuticals, Inc. (SNDX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha